These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15716397)

  • 1. Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy.
    Goodfellow JA; Bowes T; Sheikh K; Odaka M; Halstead SK; Humphreys PD; Wagner ER; Yuki N; Furukawa K; Furukawa K; Plomp JJ; Willison HJ
    J Neurosci; 2005 Feb; 25(7):1620-8. PubMed ID: 15716397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Bowes T; Wagner ER; Boffey J; Nicholl D; Cochrane L; Benboubetra M; Conner J; Furukawa K; Furukawa K; Willison HJ
    Infect Immun; 2002 Sep; 70(9):5008-18. PubMed ID: 12183547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.
    Halstead SK; O'Hanlon GM; Humphreys PD; Morrison DB; Morgan BP; Todd AJ; Plomp JJ; Willison HJ
    Brain; 2004 Sep; 127(Pt 9):2109-23. PubMed ID: 15289269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: an in and ex vivo imaging study in the mouse.
    Rupp A; Morrison I; Barrie JA; Halstead SK; Townson KH; Greenshields KN; Willison HJ
    Exp Neurol; 2012 Feb; 233(2):836-48. PubMed ID: 22197826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements of anti-GD1a antibodies determine their target specificity.
    Lopez PH; Zhang G; Bianchet MA; Schnaar RL; Sheikh KA
    Brain; 2008 Jul; 131(Pt 7):1926-39. PubMed ID: 18487279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain-Barré syndrome.
    Cunningham ME; Meehan GR; Robinson S; Yao D; McGonigal R; Willison HJ
    J Peripher Nerv Syst; 2020 Jun; 25(2):143-151. PubMed ID: 32250537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Komagamine T; Yuki N
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell response in acute motor axonal neuropathy.
    Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A
    Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Yuki N; Odaka M
    Curr Opin Neurol; 2005 Oct; 18(5):557-61. PubMed ID: 16155440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
    Halstead SK; Zitman FM; Humphreys PD; Greenshields K; Verschuuren JJ; Jacobs BC; Rother RP; Plomp JJ; Willison HJ
    Brain; 2008 May; 131(Pt 5):1197-208. PubMed ID: 18184663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice.
    McGonigal R; Rowan EG; Greenshields KN; Halstead SK; Humphreys PD; Rother RP; Furukawa K; Willison HJ
    Brain; 2010 Jul; 133(Pt 7):1944-60. PubMed ID: 20513658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
    Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
    J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy.
    Fewou SN; Rupp A; Nickolay LE; Carrick K; Greenshields KN; Pediani J; Plomp JJ; Willison HJ
    J Clin Invest; 2012 Mar; 122(3):1037-51. PubMed ID: 22307327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of age and ganglioside composition on the rate of motor nerve terminal regeneration following antibody-mediated injury in mice.
    Rupp A; Cunningham ME; Yao D; Furukawa K; Willison HJ
    Synapse; 2013 Jul; 67(7):382-9. PubMed ID: 23401234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ganglioside antibodies alter presynaptic release and calcium influx.
    Buchwald B; Zhang G; Vogt-Eisele AK; Zhang W; Ahangari R; Griffin JW; Hatt H; Toyka KV; Sheikh KA
    Neurobiol Dis; 2007 Oct; 28(1):113-21. PubMed ID: 17720506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
    Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
    Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
    [No Abstract]   [Full Text] [Related]  

  • 18. Axonal Guillain-Barré syndrome: concepts and controversies.
    Kuwabara S; Yuki N
    Lancet Neurol; 2013 Dec; 12(12):1180-8. PubMed ID: 24229616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization.
    Lunn MP; Johnson LA; Fromholt SE; Itonori S; Huang J; Vyas AA; Hildreth JE; Griffin JW; Schnaar RL; Sheikh KA
    J Neurochem; 2000 Jul; 75(1):404-12. PubMed ID: 10854286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions.
    Halstead SK; Morrison I; O'Hanlon GM; Humphreys PD; Goodfellow JA; Plomp JJ; Willison HJ
    Glia; 2005 Nov; 52(3):177-89. PubMed ID: 15968629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.